Drug Company’s Greed Coming Around to Bite Them

	Tweet

Merck faces not only Congressional and Justice Department investigations, but also potentially thousands of personal-injury lawsuits that could tie the company up in litigation for years to resolve as a result of how it dealt with Vioxx. So how bad might this get for once-mighty Merck?

While it’s impossible to say precisely what the Vioxx debacle will cost the drugmaker, analysts’ estimates range from a few billion dollars to nearly $20 billion. For now, Wall Street and some plaintiffs’ lawyers agree that the Vioxx fallout is unlikely to lead to a Merck bankruptcy.

Merck’s legal bill is likely to be considerable. The potential liability based on the fact that 20 million Americans had taken Vioxx is huge. Roughly 0.25% of those who took the drug had serious cardiovascular problems. That means some 50,000 people may have suffered consequences. Assuming that the size of average awards or settlements will range from $100,000 to $300,000, and factoring in other variables such as the likely success rate in court and added in other legal costs—including settling suits where Vioxx users didn’t suffer a major cardiovascular event.

The total hit can range from$4 billion to as high as $18 billion. But even that $18 billion figure may prove conservative; if criminal wrongdoing surfaces, in a worst-case scenario the cost could go even higher. This is exactly what is needed to level the playing field folks. These multinational drug companies are finally getting their just desserts. They have profited far too long from the public by offering them expensive options that cause serious side effects and in no way shape or form address the cause of the problem. I predict that this is the beginning of the end for the drug companies and we will see more of them crippled by their avarice for profits at the expense of human suffering.

RELATED STORIES:
Decrease Drug Costs—Go Generic   Scientist to submit Vioxx study, attorney says   New pill may help recovering alcoholics stay sober   Paxil Results Depressing Some Americans   Ranbaxy says WHO puts 7 AIDS drugs back on list   MRI Scan Can Monitor Cholesterol Health   Measures how to clamp down on Internet pharmacies   UK doctors highlight over-the-counter drug risks   US approves treatment for smallpox shot reaction   US FDA clears Barr’s generic version of Allegra   FDA Delays New Sunscreen Labeling Rules   Plague vaccine shows promise in animals

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]